We are thrilled to announce our participation in 𝐂𝐏𝐇𝐈 𝐌𝐢𝐥𝐚𝐧, one of the biggest pharmaceutical conventions of our age! Join us at booth #7B82 to accelerate your journey from molecule to market! Aurigene is a leading, global CRDMO offering end-to-end services from 𝐝𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝐭𝐨 𝐜𝐨𝐦𝐦𝐞𝐫𝐜𝐢𝐚𝐥 𝐂𝐆𝐌𝐏 𝐦𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐞 for small molecules - chemistry and biology, including oligonucleotides, PROTACs, peptides, etc., and large molecules (Biologics). With a legacy of 20 years, Aurigene stands true to its motto of "𝐆𝐨𝐨𝐝 𝐡𝐞𝐚𝐥𝐭𝐡 𝐜𝐚𝐧𝐧𝐨𝐭 𝐰𝐚𝐢𝐭!" and through 𝐜𝐮𝐭𝐭𝐢𝐧𝐠-𝐞𝐝𝐠𝐞 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 and leveraging technology like DEL and Aurigene.AI, we have dedicated ourselves to 𝐡𝐞𝐥𝐩𝐢𝐧𝐠 𝐠𝐥𝐨𝐛𝐚𝐥 𝐩𝐡𝐚𝐫𝐦𝐚 𝐚𝐧𝐝 𝐛𝐢𝐨𝐭𝐞𝐜𝐡 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 launch their innovations to market quickly, efficiently and effectively! Write to us at [email protected] to schedule a meeting with our team at CPHI'24 so we can bring your molecules to market faster! See you in Milan! #M2M #CPHIMilan #CPHI #drugmanufacturing #events2024 #pharma #drugdevelopment #gotomarket Akhil Ravi Srividya Ramakrishnan Kapil Choudhury Roger Lias ASHWINI KUMAR KAPOOR Raj Sharma (Ph.D)
Aurigene Pharmaceutical Services Limited
Pharmaceutical Manufacturing
Bangalore, Karnataka 77,776 followers
Innovation Accelerated.
About us
Aurigene Pharmaceutical Services is leading contract research, development, and manufacturing organization (CDMO). Built on the legacy of accelerating innovation and backed by a vast experience in drug discovery and development our mission is to relentlessly work for the success of our clients and to build long term relationships through a holistic approach to accelerate the journey of a molecule from laboratory to market. By providing access to our resources, knowledge and experience, we create success for our clients and ultimately patients. We offer integrated and standalone services for medicinal chemistry, biology, preclinical services, DMPK studies, development and manufacturing for clinical phase I-III programs, regulatory submission batches and commercial manufacturing. A differentiating factor is the integrated API and formulations service that spans from key starting material, advanced intermediates, APIs to finished products such as oral solids, sterile products, nasal solutions etc. Our development services in India are complemented by cGMP commercial manufacturing facilities in the UK, Mexico, USA and India. For more details, you can write to us at [email protected]
- Website
-
http://www.aurigeneservices.com/
External link for Aurigene Pharmaceutical Services Limited
- Industry
- Pharmaceutical Manufacturing
- Company size
- 501-1,000 employees
- Headquarters
- Bangalore, Karnataka
- Type
- Public Company
- Specialties
- HPAPIs, Activated mPEGS, Steroids, Formulation Services (pre-formulation, DS DP), Drug Development, biologics, Peptide, Oligonucleotides, Targeted Protein Degradation, DNA Encoded Libraries, Drug discovery, AI-assisted drug discovery, In vitro biology, DMPK, In vivo pharmacology, Microbiology, Toxicology, Custom library synthesis, Early phase development, Flow chemistry, mAbs, Bispecifics, Recombinant proteins, monoclonal antibodies, T cell redirectors, immuno-fusion molecules, Cytokines, cell line development, CGPM manufacturing, dosage formulations, solid orals, liquid orals, topical dosage , injectible formulations, ophthalmic dosage, otic dosage, nasal dosage, crystallization, polymorphism, CDMO services, CRO services, non-GMP pilot facility, and Analytical method development
Locations
-
Primary
Get directions
39-40, KIADB Industrial Area, Electronic City Phase - II, Hosur Road
Bangalore, Karnataka 560100, IN
Employees at Aurigene Pharmaceutical Services Limited
-
Sreevalsam Gopinath
Associate Vice President, DMPK at Aurigene Pharmaceutical Services Limited
-
subhashree mohanty
Individual Contributor, Graphic Designer(PORTFOLIO attached)
-
Jenny Yip
Head of US Business Development | Biologics Discovery @ Aurigene Services, part of Dr. Reddy's Laboratories
-
Sangamesh Badiger
Head - Medicinal Chemistry at Aurigene Pharmaceutical Services Ltd
Updates
-
Tushar Zade has been our visionary leader in the realm of Tech innovation at Aurigene. Join him at the ET Pharma Next Gen LabCon 2024 for interesting discussions on the future of tech in pharma! #ETPharma #Pharma #HealthcareInnovation #Techinnovation
Welcome Tushar Zade, CDO & CIO, Aurigene Pharmaceutical Services Limited, to ET Pharma Next Gen LabCon 2024 in Hyderabad on July 26th! Prepare to be inspired by his expertise and insights into the future of pharma and technology. Don't miss this opportunity! Know more- https://bit.ly/4537CYM #ETPharma #ETLabcon #Pharmaceutical #LabCon #Pharma #BigData #Compliance #GDPRCompliance #LabCon2024 #PharmaInnovation #NextGenLabCon #HyderabadEvent #BiotechRevolution
-
-
American zoologist and experimental embryologist Ross Granville Harrison was the first person to grow animal cells outside the body, in 1907. He adapted the “hanging drop” method from bacteriology for use with tissue culture, and successfully cultured frog nerve cells in clotted frog lymph. This method is now well adapted and has become a beacon for life science research advancements. #didyouknow #culturecells #lifescience #bacteriology #drugresearch
-
-
Aurigene is known for its 𝐬𝐦𝐚𝐥𝐥 𝐦𝐨𝐥𝐞𝐜𝐮𝐥𝐞 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐦𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 capabilities, helping take our clients to market much, much faster! We bring with us a legacy of 20 years, 8 𝐜𝐆𝐌𝐏 𝐠𝐥𝐨𝐛𝐚𝐥 𝐦𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 𝐬𝐢𝐭𝐞𝐬, US FDA inspected sites, and core technologies including 𝐬𝐭𝐞𝐫𝐨𝐢𝐝𝐬, 𝐇𝐏𝐀𝐏𝐈, 𝐦𝐏𝐄𝐆𝐬, 𝐂𝐚𝐫𝐛𝐨𝐡𝐲𝐝𝐫𝐚𝐭𝐞𝐬, 𝐏𝐞𝐩𝐭𝐢𝐝𝐞𝐬, etc. #drugdevelopment #smallmolecules #HealthCareInnovation #manufacturing
-
-
Congratulations on the featuring, Deenadayalan Bakthavatsalam PhD, MBA, CSSBB! It was a great pleasure working with you and the rBIO team. We look forward to more such collaborations in the future! #HealthCareInnovation #HealthandWellness
In 2020, the FDA redefined insulin as a biologic — a historic move that paved the way for the development of more affordable #biosimilars. One company traversing this regulatory pathway is rBIO, with the goal of reducing the cost of insulin with its biosimilar, R-biolin. To learn more about what it takes to develop an insulin biosimilar, I met with rBIO co-founder and president, Cameron Owen, as well as its CSO, Dr. Deenadayalan Bakthavatsalam. Read about rBIO's journey towards FDA approval for R-bioloin, as well as how it's scaling manufacturing to position itself to be a key supplier of insulin. https://lnkd.in/eg8kEE22
-
We are recognized by our customers for our cutting-edge oligonucleotide services: oligo synthesis, characterization, and biological evaluation. We synthesize 10-60 mer oligonucleotides ranging from gram to milligram scale. #DiscoveryChemistry #MedicinalChemistry #CRO #CDMO #Oligonucleotides #Innovation
-
-
🌟 Exciting News! 🌟 We are thrilled to announce that our CEO, Akhil Ravi, has been named one of India's brightest young business leaders by Economic Times 𝟰𝟬 𝗨𝗡𝗗𝗘𝗥 𝗙𝗢𝗥𝗧𝗬! 🏆. This recognition is a testament to Akhil's exceptional leadership and dedication to driving our company forward. Akhil's visionary approach and commitment to excellence have been instrumental in our growth and success. This accolade is not just a personal achievement for Akhil but a proud moment for all of us at Aurigene Pharmaceutical Services Limited. Join us in congratulating Akhil on this well-deserved honor! 🎉 #Leadership #Achievement #40Under40 #ProudMoment
-
-
If you have an innovation in the 𝐍𝐞𝐮𝐫𝐨𝐭𝐨𝐱𝐢𝐜𝐢𝐭𝐲 𝐬𝐩𝐚𝐜𝐞, we have the means to help you get to market faster! Aurigene brings to you 📌 A 𝐟𝐮𝐥𝐥𝐲 𝐚𝐮𝐭𝐨𝐦𝐚𝐭𝐢𝐜 𝐫𝐨𝐛𝐨𝐭𝐢𝐜 𝐬𝐭𝐞𝐫𝐞𝐨𝐭𝐚𝐱𝐢𝐜 and 𝐬𝐞𝐦𝐢-𝐚𝐮𝐭𝐨𝐦𝐚𝐭𝐢𝐜 𝐬𝐭𝐞𝐫𝐞𝐨𝐭𝐚𝐱𝐢𝐜 𝐚𝐩𝐩𝐚𝐫𝐚𝐭𝐮𝐬 📌 𝐄𝐭𝐡𝐨𝐯𝐢𝐬𝐢𝐨𝐧 𝐗𝐓 𝐬𝐨𝐟𝐭𝐰𝐚𝐫𝐞 from Noldus Information Technology 📌 Facilitation of multiple animal surgeries and implantation of cannula or direct administration of compounds 📌 Capacity to handle more than 600 rodents at a time 📌 𝐀𝐀𝐀𝐋𝐀𝐂 𝐚𝐜𝐜𝐫𝐞𝐝𝐢𝐭𝐞𝐝 𝐯𝐢𝐯𝐚𝐫𝐢𝐮𝐦 Let's join hands to bring your gift to the world, because as we say at Aurigene, "𝐆𝐨𝐨𝐝 𝐡𝐞𝐚𝐥𝐭𝐡 𝐜𝐚𝐧'𝐭 𝐰𝐚𝐢𝐭!" Write to us at [email protected] and let's 𝐠𝐞𝐭 𝐫𝐞𝐚𝐝𝐲 𝐭𝐨 𝐡𝐢𝐭 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭𝐬, full steam ahead! #neurotoxicity #aaalac #ethovisionxt #stereotaxic #healthcareinnovation #drugdevelopment
-
-
Aurigene come with a decade of experience in 𝐬𝐲𝐧𝐭𝐡𝐞𝐬𝐢𝐳𝐢𝐧𝐠 𝐚𝐧𝐝 𝐩𝐫𝐨𝐟𝐢𝐥𝐢𝐧𝐠 𝐏𝐑𝐎𝐓𝐀𝐂𝐬 for targeted protein degradation. With an 𝐞𝐧𝐝-𝐭𝐨-𝐞𝐧𝐝 𝐈𝐧𝐭𝐞𝐠𝐫𝐚𝐭𝐞𝐝 𝐃𝐫𝐮𝐠 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝐩𝐫𝐨𝐠𝐫𝐚𝐦 specializing in PROTACs, Aurigene has gained a competitive edge in the global market for our expertise in accelerating the molecular glue programs and taking these 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧𝐬 𝐭𝐨 𝐦𝐚𝐫𝐤𝐞𝐭 𝐟𝐚𝐬𝐭𝐞𝐫. Get in touch with our experts at [email protected] for your PROTAC requirements. Let’s join hands, because “𝐆𝐨𝐨𝐝 𝐡𝐞𝐚𝐥𝐭𝐡 𝐜𝐚𝐧𝐧𝐨𝐭 𝐰𝐚𝐢𝐭!” #protacs #integrateddrugdiscover #gotomarket #healthcareinnovations
-
-
Roger Lias, our Global Commercial Head for Biologics, has been invited as a panelist to BIOMANUFACTURING NEXT, the Bio-manufacturing Innovation Summit, being held in California. Themed as "The Anatomy of Innovation", Biomanufacturing Next is a high-level boutique round-table discussion among an expert group of key innovators, leaders and decision makers coming together to discuss on 𝐞𝐟𝐟𝐞𝐜𝐭𝐢𝐯𝐞 𝐦𝐨𝐝𝐞𝐥𝐬, 𝐜𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞𝐬, 𝐚𝐧𝐝 𝐭𝐡𝐞 𝐛𝐞𝐬𝐭 𝐰𝐚𝐲𝐬 𝐟𝐨𝐫𝐰𝐚𝐫𝐝, paving the way to the next generation of 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐯𝐞 𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥𝐬 𝐚𝐧𝐝 𝐯𝐚𝐜𝐜𝐢𝐧𝐞𝐬. 𝐌𝐞𝐞𝐭 𝐮𝐩 𝐰𝐢𝐭𝐡 𝐑𝐨𝐠𝐞𝐫 at the Biomanufacturing Next summit, and let's collaborate to get your 𝐛𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐬 𝐢𝐝𝐞𝐚 𝐦𝐞𝐞𝐭 𝐢𝐭𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐟𝐚𝐬𝐭𝐞𝐫! Write to us at [email protected] and we'll connect you with Roger for an insightful hello! #largemolecules #paneldiscussion #biomanufacturing #biotechnology #bioinnovators
-